Steno780G Follow-up Study

Steno Diabetes Centers

Status: Not yet enrolling

Conditions: Type 1 Diabetes

Treatments: Device: 780G AID pump

Study type: Observational

Funder types: Other

Identifiers

NCT07474155

Steno780G-Followup

Details and patient eligibility

About

Automated insulin delivery systems, also known as closed-loop systems, have shown to improve TIR, TAR, and TBR compared with insulin pump and CGM systems that cannot automatically dose insulin. Only few studies have described long-term use of AID systems over several years. Real-world studies suggest that the beneficial effects of AID systems on glycemic outcomes are sustained over time; however, a modest increase in body weight has been observed in some users, raising concerns about the metabolic trade-offs of improved glycemia. We aim to explore wether the improvements in glycemic outcomes and treatment satisfaction achieved with AID systems remain stable over multiple years, and secondly, if long-term treatment with AID systems may be associated with an increase in body weight.

Full description

40 participants, who have completed the Steno780G trial, will be invited to attend a follow-up visit at Steno Diabetes Center Copenhagen between 3.5 - 4.5 years after start of AID treatment to assess the long-term effects of the MiniMed 780G system.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Previous participation in the Steno780G study

Exclusion criteria

• Lack of compliance with key study procedures at the discretion of the investigator.

Trial design

40 participants in 1 patient group

Cohort of 780G users

Description:

Cohort of 780G users who previously participated in the Steno780G trial

Treatment:

Device: 780G AID pump